Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
Long-read sequencing unearths overlooked autism-linked variants
Strips that are thousands of base pairs in length offer better resolution of structural variants and tandem repeats, according to two independent preprints.
Long-read sequencing unearths overlooked autism-linked variants
Strips that are thousands of base pairs in length offer better resolution of structural variants and tandem repeats, according to two independent preprints.
This paper changed my life: Dan Goodman on a paper that reignited the field of spiking neural networks
Friedemann Zenke’s 2019 paper, and its related coding tutorial SpyTorch, made it possible to apply modern machine learning to spiking neural networks. The innovation reinvigorated the field.
This paper changed my life: Dan Goodman on a paper that reignited the field of spiking neural networks
Friedemann Zenke’s 2019 paper, and its related coding tutorial SpyTorch, made it possible to apply modern machine learning to spiking neural networks. The innovation reinvigorated the field.
Autism and anxiety insights; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 September.
Autism and anxiety insights; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 September.